The effects of NS5A inhibitors on NS5A phosphorylation, polyprotein processing and localization
- PMID: 21795470
- DOI: 10.1099/vir.0.034801-0
The effects of NS5A inhibitors on NS5A phosphorylation, polyprotein processing and localization
Abstract
Hepatitis C virus (HCV) non-structural protein 5A (NS5A) is a multi-functional protein that is expressed in basally phosphorylated (p56) and in hyperphosphorylated (p58) forms. NS5A phosphorylation has been implicated in regulating multiple aspects of HCV replication. We recently reported the identification of a class of compounds that potently inhibit HCV RNA replication by targeting NS5A. Although the precise mechanism of inhibition of these compounds is not well understood, one activity that has been described is their ability to block expression of the hyperphosphorylated form of NS5A. Here, we report that an NS5A inhibitor impaired hyperphosphorylation without affecting basal phosphorylation at the C-terminal region of NS5A. This inhibitor activity did not require NS5A domains II and III and was distinct from that of a cellular kinase inhibitor that also blocked NS5A hyperphosphorylation, results that are consistent with an inhibitor-binding site within the N-terminal region of NS5A. In addition, we observed that an NS5A inhibitor promoted the accumulation of an HCV polyprotein intermediate, suggesting that inhibitor binding to NS5A may occur prior to the completion of polyprotein processing. Finally, we observed that NS5A p56 and p58 separated into different membrane fractions during discontinuous sucrose gradient centrifugation, consistent with these NS5A phosphoforms performing distinct replication functions. The p58 localization pattern was disrupted by an NS5A inhibitor. Collectively, our results suggest that NS5A inhibitors probably impact several aspects of HCV expression and regulation. These findings may help to explain the exceptional potency of this class of HCV replication complex inhibitors.
Similar articles
-
Daclatasvir inhibits hepatitis C virus NS5A motility and hyper-accumulation of phosphoinositides.Virology. 2015 Feb;476:168-179. doi: 10.1016/j.virol.2014.12.018. Epub 2014 Dec 26. Virology. 2015. PMID: 25546252 Free PMC article.
-
Characterization of a Threonine-Rich Cluster in Hepatitis C Virus Nonstructural Protein 5A and Its Contribution to Hyperphosphorylation.J Virol. 2018 Nov 27;92(24):e00737-18. doi: 10.1128/JVI.00737-18. Print 2018 Dec 15. J Virol. 2018. PMID: 30258001 Free PMC article.
-
Characterizations of HCV NS5A replication complex inhibitors.Virology. 2013 Sep;444(1-2):343-54. doi: 10.1016/j.virol.2013.06.032. Epub 2013 Jul 27. Virology. 2013. PMID: 23896639
-
The non-structural 5A protein of hepatitis C virus.J Viral Hepat. 1999 Sep;6(5):343-56. doi: 10.1046/j.1365-2893.1999.00185.x. J Viral Hepat. 1999. PMID: 10607250 Review.
-
Antiviral activity and resistance of HCV NS5A replication complex inhibitors.Curr Opin Virol. 2013 Oct;3(5):514-20. doi: 10.1016/j.coviro.2013.06.014. Epub 2013 Jul 27. Curr Opin Virol. 2013. PMID: 23896281 Review.
Cited by
-
The crystal structure of NS5A domain 1 from genotype 1a reveals new clues to the mechanism of action for dimeric HCV inhibitors.Protein Sci. 2014 Jun;23(6):723-34. doi: 10.1002/pro.2456. Epub 2014 Apr 5. Protein Sci. 2014. PMID: 24639329 Free PMC article.
-
Daclatasvir: potential role in hepatitis C.Drug Des Devel Ther. 2013 Oct 16;7:1223-33. doi: 10.2147/DDDT.S40310. eCollection 2013. Drug Des Devel Ther. 2013. PMID: 24204123 Free PMC article. Review.
-
Daclatasvir combined with peginterferon-α and ribavirin for the treatment of chronic hepatitis C: a meta-analysis.Springerplus. 2016 Sep 15;5(1):1569. doi: 10.1186/s40064-016-3218-x. eCollection 2016. Springerplus. 2016. PMID: 27652142 Free PMC article. Review.
-
Intragenic complementation of hepatitis C virus NS5A RNA replication-defective alleles.J Virol. 2013 Feb;87(4):2320-9. doi: 10.1128/JVI.02861-12. Epub 2012 Dec 12. J Virol. 2013. PMID: 23236071 Free PMC article.
-
HCV NS5A dimer interface residues regulate HCV replication by controlling its self-interaction, hyperphosphorylation, subcellular localization and interaction with cyclophilin A.PLoS Pathog. 2018 Jul 23;14(7):e1007177. doi: 10.1371/journal.ppat.1007177. eCollection 2018 Jul. PLoS Pathog. 2018. PMID: 30036383 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials